Francisella tularensis, a facultative intracellular bacterium, initiates a potentially fatal human disease called tularemia. Disease manifestation depends upon the route of inoculation and ranges from ulceroglandular infection (entry through the skin) to respiratory tularemia (inhalation) to a typhoidal disease (unknown route of entry). Regardless of the initial site of infection, pneumonia is a common sequela of tularemia (13) . Survival ensures lifelong immunity to reinfection (20) . A relatively avirulent Francisella strain, the live vaccine strain (LVS), is used as a vaccine in humans, albeit with only variable effectiveness, to protect against virulent F. tularensis (4, 22) . This vaccine strain itself, however, is fully pathogenic for certain animals and causes a lethal infection in mice that is indistinguishable from human disease (1, 6) . Thus, the mouse is an extremely useful animal model for analysis of host response during tularemia.
In early studies with LVS, cells and serum from immune animals were transferred to nonimmune recipients to assess the role of each in protection against virulent F. tularensis challenge. These studies suggest that LVS-immune cells, not serum, mediate protective immunity against infections with wild-type Francisella strains (7, 21) . Two survived infection for 10 days remained alive through 30 days. The LD50 for four of the six mouse strains tested was approximately 1 CFU (range, 1 to 5 CFU, n = 5). Modest genetically based resistance was suggested by the LD50 for CS7BL/6J mice, which was 700 organisms, and that for C3H/HeJ mice, which was 50 organisms.
To determine the primary site(s) of bacterial replication in susceptible strains, we removed various organs from BALB/c or C3H/HeN mice inoculated i.p. with 103 LVS organisms. Bacteriological examination of the tissues revealed early involvement of reticuloendothelial organs: spleen, liver, and lungs ( Fig. 1 ). There was a logarithmic increase in the number of viable LVS cells cultured from these tissues over time. LVS infection of these organs persisted until the death of the animal. Examination of the tissues revealed pathological changes in both the spleen and the liver: necrotic foci with inflammatory infiltrates, primarily neutrophils and monocytes, were evident. Organisms were not found in other tissues examined (heart, stomach, kidneys).
The two most susceptible mouse strains, C3H/HeN and BALB/c, were infected by intravenous (i.v.) inoculation of LVS ( counts in the liver and lungs increased. Bacterial counts in the spleens of infected animals 7 days after inoculation (a time at which animals were moribund) actually decreased. Histopathological examination of the infected tissues again showed inflammatory lesions that progressed from acute to necrotizing over time. These lesions, however, were different from those resulting from i.p. inoculation: the lesions were granulomatous by 7 days.
To simulate the natural route of infection by aerosolization in the two most susceptible strains, we anesthetized C3H/ HeN and BALB/c mice and administered LVS intranasally (i.n.) in a total volume of 50 ,ul. As with the other two routes of inoculation, animals were sick by 3 days, moribund by 5 for BALB/c mice by this route was 100 CFU (Table 2) . Microbiological examination of the tissues from inoculated mice revealed bacteria in the spleen, liver, and lungs by 3 days after inoculation (Fig. 1) . These organs remained infected for 8 days after inoculation. Bacteria were not isolated from kidney, heart, or stomach tissues. Gross pathological examination of i.n. inoculated animals indicated pulmonary involvement: all affected mice developed dyspnea by 3 days. Histopathological examination of lung tissue showed that bronchopneumonia was evident by 3 days and became necrotizing at 6 days. At 6 days, livers had foci of acute inflammation with necrosis that became granulomatous by 8 days. At 6 and 8 days, spleens were enlarged and there was significant proliferation of mononuclear cells in periarteriolar lymphoid sheaths.
The other natural route of human infection is through the dermis. To determine whether mice were susceptible to LVS given by this route, we inoculated three mouse strains, C57BL/6J, C3H/HeN, and BALB/c, with a dose of LVS that was fatal by any other route of inoculation. All animals survived an intradermal (i.d.) inoculation (base of the tail) with 10' LVS cells. We attempted to calculate LD50s for two of the strains, C3H/HeN and BALB/c, but fewer than 50% of the BALB/c mice died after an i.d. inoculation of 107 organisms. C3H/HeN mice were more susceptible to this route, since the LD50 was 105'5 (Table 2 ).
It was possible that animals survived i.d. inoculation because the bacterium did not metastasize from the site of inoculation. Organ distribution of LVS in i.d.-inoculated mice, however, did not differ from that found after other routes of inoculation: bacteria were isolated from the spleen, liver, and lungs (Fig. 1) . Additionally, initial growth of the bacterium within these tissues was not different from that seen by the other routes. The only differences of note were the times for these organs to acquire a particular number of bacteria ( (Table 4) . To further characterize the protective cells in this transfer system, we treated immune spleen cells with a cocktail of anti-Thyl.2, anti-CD4, and anti-CD8 antibodies and complement to remove T cells. The resulting cells, found to be 82% surface Ig+ by FACS analysis, were unable to protect mice from lethal LVS infection (Table 4) .
DISCUSSION
There are a number of infections with the same microorganism that appear as distinct diseases depending on the site of pathogen inoculation. Cutaneous disease is generally initiated by direct contact at a skin site. Systemic infections result either from spread of the agent via vascularization and hematological dissemination to other organs, or from direct infection (in the lungs, for instance, by inhalation of the infectious agent). Sporotrichosis, a fungal disease caused by Sporothrix schenckii, has three distinct forms depending on the route of inoculation: a cutaneous lesion develops at the site of skin contact with spores, a chronic pneumonia develops as a result of inhalation of spores, and a disseminated form can result from lymphatic or hematologic spread from either of these primary sites (19) . Bacillus anthracis the bacterium responsible for anthrax, causes a cutaneous infection if inoculation is through the skin, but a pulmonary infection if the route of inoculation is by inhalation of spores (8) . Brucellosis, erysipeloid, glanders, plague, and tularemia all have cutaneous manifestations as well as systemic forms of disease (14, 18, 19, 23) . In human tularemia, the usual route of entry is through the skin, which leads to development of ulceroglandular disease. There is lymph node involvement, and dissemination can occur via the blood. F. tularensis may also be transmitted via aerosols to the lungs. This route of inoculation leads to pulmonary disease that, if untreated, is fatal in up to 60% of cases. The ulceroglandular form of the disease has a fatality rate of only 5% if untreated (19, 20) . The mechanisms responsible for these differences based on route of inoculation have not been elucidated for any of the infectious diseases described above. It is still not known which local mechanisms, specific or nonspecific, play a role in protection. If the host is competent to mount an effective immune response, why are these mechanisms not effective during systemic disease?
F. tularensis LVS infection in mice is similarly dependent on the route of inoculation. i.p., i.v., and i.n. inoculation all lead to early reticuloendothelial involvement (1 to 3 days) and bacterial growth within tissues of the lungs, liver, and spleen. There appear to be some minor differences in the host response to challenge by these different routes. Bacterial growth slows, and there is late (after 7 days) granuloma development following i.v. and i.n. inoculation, but not i.p. inoculation. Eventually, however, the majority of the mice die after an initial inoculum of less than 1,000 CFU ( Since the organism establishes an infection in the liver and spleen by 2 to 3 days in i.d. inoculations, just as in lethal disease, the protective response must be initiated early. The earliest event in i.d. inoculation is initial contact of the bacterium-with local skin cells. Of particular interest to this study is the potential role of T cells expressing yB receptors (3) . The potential importance of this particular T-cell lineage in the Francisella infection model is suggested by the strategic location of -yb cells in the skin (10) and by the functional abilities of these cells to recognize major histocompatibility complex-linked antigens (12) , produce lymphokines (17), develop cytotoxic potential (15) , and react to bacterial heat shock proteins (17) . T cells expressing yS receptors have recently been implicated in development of the primary immune response to Mycobacterium tuberculosis, another intracellular organism (9) . The characterization of this routedependent variation in development of immunity to Francisella infection in C3H/HeN mice will enable us to examine the role of -yb T cells in tularemia.
Passive transfer of immunity to lethal LVS infections with both serum and cells (Table 4) suggests that protective host responses to this vaccine strain during primary disease differ from those that influence resistance to the wild-type Francisella strain. In earlier studies that focused on LVS as a vaccine rather than a pathogen, only cells from vaccinated animals were capable of adoptively transferring immunity to virulent F. tularensis (7, 21 ). Here we demonstrate that serum is quite effective in protecting mice from i.p. LVS infections, and we recently generated a monoclonal antibody reactive with LVS that also protects mice from lethal disease (16) . That cells can passively transfer protection against lethal i.p. LVS infections was suggested by earlier studies involving challenge with the virulent wild-type pathogen (7, 21) . The nature of the protective cells effective in these earlier studies was never determined. We find that the transfer of immunity to LVS infection by spleen cells is far more complicated than anticipated: whole immune spleen cells and nonadherent immune spleen cells, but not B cells, passively transferred protection, and this protection was specific for Francisella species (Table 4) . However, a number of our experiments (data not shown) suggest that protection is not mediated by the classic CD4 T-cell component of immune spleen cells. We have yet to determine the precise phenotype of the protective cells in our system, but these studies are under way.
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